AI-generated summary
The authors studied 132 adults with rheumatoid arthritis, comparing 102 patients who received intravenous laser irradiation of the blood plus standard medication with 30 who received standard medication alone. They report that the combined treatment was accompanied by normalized plasma leptin levels, reduced inflammation and improved quality of life. The abstract does not state the laser wavelength.
- Participants
- 132
- Who or what was studied
- Adults aged 18 to 65 with rheumatoid arthritis, divided into a combined-treatment group (n = 102) and a control group receiving standard medication alone (n = 30).
- Limits stated in the abstract
- The abstract does not report randomization, blinding or the exact laser parameters, and the control group was smaller than the treatment group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on mediasphera.ru.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.